drugset / Trial / NCT05846139

Slow-release Locally Administered 0.02% Hypochlorite Formulation

NCT05846139

Completed 40 enrolled Tuscan Dental Institute
RandomizedParallel-groupSingle-blindSupportive care

Summary

Aim: The presence of bacterial plaque is associated with the development of periodontal inflammation. The aim of this single-blind randomized clinical study was to prospectively evaluate the efficacy of two different agents in a staged approach for nonsurgical periodontal treatment in terms of clinical and patients related outcomes in a cohort of patients with periodontitis: NitrAdine® based disinfectant formula (PerioTabs®) vs Chlorhexidine 0.12 toothpaste and mouthwash 0.20. Material and methods: Patients with a diagnosis of periodontal disease (stage I-III) scheduled for non surgical periodontal treatment were randomly allocated to the preparatory home use of a chlorhexidine mouthwash or a NitrAdine® based brushing solution called PerioTabs® for 10-15 days. Active decontamination with ultrasonic scalers was performed after the completion of the preparation period. Clinical and patient-related outcomes were recorded at baseline, at the moment of professional intervention, and after 30 and 90 days from baseline.

Timeline

Start
2022-01-17
Primary completion
2022-11-21
Completion
2022-11-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Chlorhexidine Small molecule 0.12 % Topical
Subject Chlorhexidine Small molecule 0.2 % Topical
Subject PerioTabs Unknown 0.02 % Topical

Indications